Product
CEP-33457
Aliases
Lupuzor
2 clinical trials
1 indication
Indication
Systemic Lupus ErythematosusClinical trial
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of CEP-33457 in Patients With Systemic Lupus ErythematosusStatus: Completed, Estimated PCD: 2012-01-31
Clinical trial
An Open-Label Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus ErythematosusStatus: Terminated, Estimated PCD: 2012-06-14